France · Source-listed medicine information

France / CIS 67181796

BIONOLYTE G5, solution pour perfusion

solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution pour perfusion
Routeintraveineuse
Ingredient entries4
CountryFrance

Product identity

At a glance

Authorisation holder
FRESENIUS KABI FRANCE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 67181796

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for BIONOLYTE G5, solution pour perfusion
IngredientStrength / referenceSource role
POTASSIUM (CHLORURE DE)solution0,2 g100 mlSAGroup 1
GLUCOSE ANHYDREsolution5,0 g100 mlFTGroup 3
SODIUM (CHLORURE DE)solution0,4 g100 mlSAGroup 2
GLUCOSE MONOHYDRATÉsolution5,5 g100 mlSAGroup 3

Pack references

Presentations (6)

1 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 500 ml

CIP13 3400936750234

Présentation active · Déclaration de commercialisation
1 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 1000 ml

CIP13 3400936750463

Présentation active · Déclaration de commercialisation
10 flacon(s) polyéthylène de 500 ml

CIP13 3400938377095

Présentation active · Déclaration de commercialisation
10 flacon(s) polyéthylène de 1000 ml

CIP13 3400938377385

Présentation active · Déclaration de commercialisation
20 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 500 ml

CIP13 3400938551792

Présentation active · Déclaration de commercialisation
10 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 1000 ml

CIP13 3400938554755

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 67181796 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →